Delayed speech and language development, and Optic atrophy

Diseases related with Delayed speech and language development and Optic atrophy

In the following list you will find some of the most common rare diseases related to Delayed speech and language development and Optic atrophy that can help you solving undiagnosed cases.


Top matches:

Medium match VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0

Vitamin B12-unresponsive methylmalonic acidemia type mut0 is an inborn error of metabolism characterized by recurrent ketoacidotic comas or transient vomiting, dehydration, hypotonia and intellectual deficit, which does not respond to administration of vitamin B12.

VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0 Is also known as complete deficiency of methylmalonyl-coa mutase; vitamin b12-unresponsive methylmalonic aciduria type mut0

Related symptoms:

  • Intellectual disability
  • Global developmental delay
  • Growth delay
  • Muscular hypotonia
  • Anemia


SOURCES: UMLS ORPHANET

More info about VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0

Medium match MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4

MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4 Is also known as ;

Related symptoms:

  • Autosomal recessive inheritance
  • Spasticity
  • Optic atrophy
  • Absent speech
  • Leukodystrophy


SOURCES: OMIM MONDO ORPHANET UMLS DOID

More info about MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4

Medium match AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA

ANOA is an autosomal recessive neurologic disorder characterized by onset of visual and hearing impairment in the first or second decades (summary by Paul et al., 2017).

Related symptoms:

  • Hearing impairment
  • Nystagmus
  • Visual impairment
  • Peripheral neuropathy
  • Delayed speech and language development


SOURCES: OMIM

More info about AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA

Mendelian

Too many results?
We can help you with your rare disease diagnosis.

Learn more

Other less relevant matches:

Medium match SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4

SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4 Is also known as ;autosomal recessive spastic ataxia type 4; spax4

Related symptoms:

  • Autosomal recessive inheritance
  • Ataxia
  • Nystagmus
  • Motor delay
  • Delayed speech and language development


SOURCES: ORPHANET UMLS DOID GARD OMIM MONDO

More info about SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4

Medium match SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12

Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency is a rare autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome characterized by early-childhood onset of cerebellar ataxia associated with generalized tonic-clonic epilepsy and psychomotor development delay, dysarthria, gaze-evoked nystagmus and learning disability. Other features in some patients include upper motor neuron signs with leg spasticity and extensor plantar responses, and mild cerebellar atrophy on brain MRI.

SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12 Is also known as spinocerebellar ataxia with mental retardation and epilepsy;autosomal recessive spinocerebellar ataxia type 12; scar12

Related symptoms:

  • Autosomal recessive inheritance
  • Intellectual disability
  • Seizures
  • Global developmental delay
  • Microcephaly


SOURCES: MONDO ORPHANET UMLS OMIM DOID

More info about SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12

Medium match CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2

The neuronal ceroid lipofuscinoses (NCL; CLN) are a clinically and genetically heterogeneous group of neurodegenerative disorders characterized by the intracellular accumulation of autofluorescent lipopigment storage material in different patterns ultrastructurally. The clinical course includes progressive dementia, seizures, and progressive visual failure. The lipopigment pattern seen most often in CLN2 consists of 'curvilinear' profiles (Mole et al., 2005).For a general phenotypic description and a discussion of genetic heterogeneity of CLN, see CLN1 (OMIM ).

CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2 Is also known as ceroid lipofuscinosis, neuronal, 2, variable age at onset, jansky-bielschowsky disease

Related symptoms:

  • Autosomal recessive inheritance
  • Seizures
  • Pica
  • Ataxia
  • Visual impairment


SOURCES: OMIM

More info about CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2

Medium match NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5

NBIA5, sometimes referred to as 'static encephalopathy of childhood with neurodegeneration in adulthood (SENDA),' is an X-linked neurodegenerative disorder characterized by global developmental delay in early childhood that is essentially static, with slow motor and cognitive gains until adolescence or early adulthood. In young adulthood, affected individuals develop progressive dystonia, parkinsonism, extrapyramidal signs, and dementia resulting in severe disability. Brain MRI shows iron accumulation in the globus pallidus and substantia nigra. A characteristic finding is T1-weighted hyperintensity surrounding a central band of hypointensity in the substantia nigra. Cerebral and cerebellar atrophy are also observed (summary by Haack et al., 2012 and Saitsu et al., 2013).For a general phenotypic description and a discussion of genetic heterogeneity of NBIA, see NBIA1 (OMIM ).

NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5 Is also known as beta-propeller protein-associated neurodegeneration;bpan, static encephalopathy of childhood with neurodegeneration in adulthood;senda;bpan; nbia5; neurodegeneration with brain iron accumulation type 5; senda; static encephalopathy of childhood with neurdegeneration in adulthood

Related symptoms:

  • Intellectual disability
  • Seizures
  • Global developmental delay
  • Motor delay
  • Spasticity


SOURCES: SCTID DOID ORPHANET GARD OMIM MONDO UMLS

More info about NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5

Medium match STRIATONIGRAL DEGENERATION, INFANTILE; SNDI

Bilateral striatal necrosis (BSN) encompasses a heterogeneous group of neurologic disorders with different causation. Familial infantile striatal degeneration is rare and can be inherited as an autosomal recessive or mitochondrial (see {500003}) disorder. The familial form has an insidious onset and a slowly progressive course; the sporadic form is associated with acute systemic illness. Many features of BSN overlap with Leigh syndrome (OMIM ) and certain metabolic disorders, including glutaric acidemia I (OMIM ) and methylmalonic aciduria (OMIM ). See also Aicardi-Goutieres syndrome (OMIM ) (Mito et al., 1986; De Meirleir et al., 1995). Genetic Heterogeneity of Stiatonigral DegenerationChildhood-onset striatonigral degeneration (OMIM ) is caused by mutation in the VAC14 gene (OMIM ) on chromosome 16q22.See also adult-onset autosomal dominant striatal degeneration (ADSD ), caused by mutation in the PDE8B gene (OMIM ) on chromosome 5q13.

STRIATONIGRAL DEGENERATION, INFANTILE; SNDI Is also known as infantile bilateral striatal necrosis;ibsn, bilateral striatal necrosis, infantile, striatal degeneration, familial

Related symptoms:

  • Autosomal recessive inheritance
  • Intellectual disability
  • Seizures
  • Ataxia
  • Nystagmus


SOURCES: OMIM ORPHANET

More info about STRIATONIGRAL DEGENERATION, INFANTILE; SNDI

Medium match EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3

Mutations in the KCTD7 gene cause a severe neurodegenerative phenotype characterized by onset of intractable myoclonic seizures before age 2 years and accompanied by developmental regression. The initial description was consistent with a form of progressive myoclonic epilepsy (designated here as EPM3), whereas a later report identified intracellular accumulation of autofluorescent lipopigment storage material, consistent with neuronal ceroid lipofuscinosis (designated CLN14). Ultrastructural findings on skin biopsies thus appear to be variable. However, clinical features are generally consistent between reports (summary by Staropoli et al., 2012).For a general phenotypic description and a discussion of genetic heterogeneity of progressive myoclonic epilepsy, see EPM1A (254800).For a general phenotypic description and a discussion of genetic heterogeneity of neuronal ceroid lipofuscinosis, see CLN1 (OMIM ).

EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3 Is also known as ceroid lipofuscinosis, neuronal, 14;cln14;epm3; pme type 3; progressive myoclonic epilepsy due to kctd7 deficiency; progressive myoclonus epilepsy type 3

Related symptoms:

  • Autosomal recessive inheritance
  • Intellectual disability
  • Seizures
  • Microcephaly
  • Scoliosis


SOURCES: MESH OMIM ORPHANET GARD MONDO UMLS

More info about EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3

Medium match 3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9

MGCA9 is an autosomal recessive disorder characterized by early-onset seizures, severely delayed psychomotor development and intellectual disability. Patients have hypotonia or spasticity, and laboratory investigations show increased serum lactate and 3-methylglutaconic aciduria, suggestive of a mitochondrial defect (summary by Shahrour et al., 2017).For a phenotypic description and a discussion of genetic heterogeneity of 3-methylglutaconic aciduria, see MGCA type I (OMIM ).

3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9 Is also known as ;3-methylglutaconic aciduria-epilepsy-spasticity-severe intellectual disability syndrome; mga9

Related symptoms:

  • Intellectual disability
  • Seizures
  • Global developmental delay
  • Generalized hypotonia
  • Failure to thrive


SOURCES: MONDO ORPHANET UMLS OMIM

More info about 3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9

Top 5 symptoms//phenotypes associated to Delayed speech and language development and Optic atrophy

Symptoms // Phenotype % cases
Intellectual disability Common - Between 50% and 80% cases
Seizures Common - Between 50% and 80% cases
Autosomal recessive inheritance Common - Between 50% and 80% cases
Neurodegeneration Uncommon - Between 30% and 50% cases
Absent speech Uncommon - Between 30% and 50% cases
Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Other less frequent symptoms

Patients with Delayed speech and language development and Optic atrophy. may also develop some of the following symptoms:

Uncommon Symptoms - Between 30% and 50% cases


Spasticity Ataxia Global developmental delay Dysarthria Myoclonus Nystagmus Clonus Cerebellar atrophy Mental deterioration Motor delay Cerebral atrophy Neuronal loss in central nervous system Dystonia

Rare Symptoms - Less than 30% cases


Hypertonia Hyporeflexia Babinski sign Failure to thrive Gliosis Abnormality of eye movement Dysphagia Spastic paraparesis Limb ataxia Generalized seizures Paraparesis Ranula Developmental regression Retinopathy Microcephaly Visual loss Dementia Retinal degeneration Encephalopathy Growth delay Choreoathetosis Rod-cone dystrophy Nausea and vomiting Visual impairment Total ophthalmoplegia Abnormal autonomic nervous system physiology Vomiting Milia Muscular hypotonia Iron accumulation in substantia nigra Iron accumulation in brain Frontal release signs Progressive encephalopathy Bradykinesia X-linked dominant inheritance Athetosis Sleep disturbance Parkinsonism Poor speech Anemia Paraplegia Hepatomegaly Spastic paraplegia Aggressive behavior Rigidity Renal insufficiency Abnormality of the eye Involuntary movements Nausea Focal myoclonic seizures Abnormality of mitochondrial metabolism Epileptic encephalopathy Hypsarrhythmia Brain atrophy Increased serum lactate Aciduria Abnormality of the cerebral white matter Arrhythmia Muscle weakness Generalized hypotonia Fingerprint intracellular accumulation of autofluorescent lipopigment storage material Gait disturbance Truncal ataxia Status epilepticus Cutaneous photosensitivity Generalized myoclonic seizures Progressive Hypoplasia of the corpus callosum Fever Scoliosis Abnormality of the basal ganglia Developmental stagnation Pendular nystagmus Tremor Mitochondrial encephalopathy Increased extraneuronal autofluorescent lipopigment Vegetative state Hemiplegia/hemiparesis Renal tubular dysfunction Leukodystrophy Upper limb hypertonia Movement abnormality of the tongue Lower limb hypertonia Spastic ataxia Progressive gait ataxia Emotional lability Abnormality of the periventricular white matter Hearing impairment Hyperammonemia Frequent falls Progressive cerebellar ataxia Falls Peripheral neuropathy Slow progression Edema Pallor Hyperreflexia Ophthalmoplegia Optic disc pallor Gait ataxia Pancreatitis Abnormal nervous system electrophysiology Tetraparesis Papilledema Curvilinear intracellular accumulation of autofluorescent lipopigment storage material Increased neuronal autofluorescent lipopigment Retinal thinning Undetectable electroretinogram Motor deterioration Atonic seizures Abnormal electroretinogram Macular degeneration Progressive visual loss Coma Gaze-evoked nystagmus Retinal detachment Respiratory distress Thrombocytopenia Lethargy Neutropenia Sepsis Chorea Blindness Pica Urinary bladder sphincter dysfunction 3-Methylglutaconic aciduria


If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like Hydrocephalus and Microtia, related diseases and genetic alterations Epicanthus and Upslanted palpebral fissure, related diseases and genetic alterations Strabismus and Pancytopenia, related diseases and genetic alterations Generalized hypotonia and Hypertriglyceridemia, related diseases and genetic alterations Hearing impairment and Osteosarcoma, related diseases and genetic alterations Hearing impairment and Retinal detachment, related diseases and genetic alterations Macrocephaly and Rigidity, related diseases and genetic alterations